1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Opioids Drug Consumption 2016-2026

2.1.2 Opioids Drug Consumption CAGR by Region

2.2 Opioids Drug Segment by Type

2.2.1 Oxycodone

2.2.2 Hydromorphone

2.2.3 Codeine

2.2.4 Fentanyl

2.2.5 Others

2.3 Opioids Drug Sales by Type

2.3.1 Global Opioids Drug Sales Market Share by Type (2016-2021)

2.3.2 Global Opioids Drug Revenue and Market Share by Type (2016-2021)

2.3.3 Global Opioids Drug Sale Price by Type (2016-2021)

2.4 Opioids Drug Segment by Application

2.4.1 Pain Relief

2.4.2 Anesthesia

2.4.3 Others

2.5 Opioids Drug Sales by Application

2.5.1 Global Opioids Drug Sale Market Share by Application (2016-2021)

2.5.2 Global Opioids Drug Revenue and Market Share by Application (2016-2021)

2.5.3 Global Opioids Drug Sale Price by Application (2016-2021)

3 Global Opioids Drug by Company

3.1 Global Opioids Drug Sales Market Share by Company

3.1.1 Global Opioids Drug Sales by Company (2019-2021)

3.1.2 Global Opioids Drug Sales Market Share by Company (2019-2021)

3.2 Global Opioids Drug Revenue Market Share by Company

3.2.1 Global Opioids Drug Revenue by Company (2019-2021)

3.2.2 Global Opioids Drug Revenue Market Share by Company (2019-2021)

3.3 Global Opioids Drug Sale Price by Company

3.4 Global Manufacturers Opioids Drug Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Opioids Drug Product Location Distribution

3.4.2 Players Opioids Drug Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 Opioids Drug by Region

4.1 Global Opioids Drug by Region

4.1.1 Global Opioids Drug Sales by Region

4.1.2 Global Opioids Drug Revenue by Region

4.2 Americas Opioids Drug Sales Growth

4.3 APAC Opioids Drug Sales Growth

4.4 Europe Opioids Drug Sales Growth

4.5 Middle East & Africa Opioids Drug Sales Growth

5 Americas

5.1 Americas Opioids Drug Sales by Country

5.1.1 Americas Opioids Drug Sales by Country (2016-2021)

5.1.2 Americas Opioids Drug Revenue by Country (2016-2021)

5.2 Americas Opioids Drug Sales by Type

5.3 Americas Opioids Drug Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Opioids Drug Sales by Region

6.1.1 APAC Opioids Drug Sales by Region (2016-2021)

6.1.2 APAC Opioids Drug Revenue by Region (2016-2021)

6.2 APAC Opioids Drug Sales by Type

6.3 APAC Opioids Drug Sales by Application

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Opioids Drug by Country

7.1.1 Europe Opioids Drug Sales by Country (2016-2021)

7.1.2 Europe Opioids Drug Revenue by Country (2016-2021)

7.2 Europe Opioids Drug Sales by Type

7.3 Europe Opioids Drug Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Opioids Drug by Country

8.1.1 Middle East & Africa Opioids Drug Sales by Country (2016-2021)

8.1.2 Middle East & Africa Opioids Drug Revenue by Country (2016-2021)

8.2 Middle East & Africa Opioids Drug Sales by Type

8.3 Middle East & Africa Opioids Drug Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Country

9 Market Drivers, Challenges and Trends

9.1 Market Drivers and Impact

9.1.1 Growing Demand from Key Regions

9.1.2 Growing Demand from Key Applications and Potential Industries

9.2 Market Challenges and Impact

9.3 Market Trends

10 Marketing, Distributors and Customer

10.1 Sales Channel

10.1.1 Direct Channels

10.1.2 Indirect Channels

10.2 Opioids Drug Distributors

10.3 Opioids Drug Customer

11 Global Opioids Drug Market Forecast

11.1 Global Opioids Drug Forecast by Region

11.1.1 Global Opioids Drug Forecast by Regions (2021-2026)

11.2.2 Global Opioids Drug Revenue Forecast by Regions (2021-2026)

11.2 Americas Forecast by Country

11.3 APAC Forecast by Region

11.4 Europe Forecast by Country

11.5 Middle East & Africa Forecast by Country

11.6 Global Opioids Drug Forecast by Type

11.7 Global Opioids Drug Forecast by Application

12 Key Players Analysis

12.1 Teva

12.1.1 Teva Company Information

12.1.2 Teva Opioids Drug Product Offered

12.1.3 Teva Opioids Drug Sales, Revenue, Price and Gross Margin (2019-2021)

12.1.4 Teva Main Business Overview

12.1.5 Teva Latest Developments

12.2 Purdue Pharma

12.2.1 Purdue Pharma Company Information

12.2.2 Purdue Pharma Opioids Drug Product Offered

12.2.3 Purdue Pharma Opioids Drug Sales, Revenue, Price and Gross Margin (2019-2021)

12.2.4 Purdue Pharma Main Business Overview

12.2.5 Purdue Pharma Latest Developments

12.3 Mallinckrodt

12.3.1 Mallinckrodt Company Information

12.3.2 Mallinckrodt Opioids Drug Product Offered

12.3.3 Mallinckrodt Opioids Drug Sales, Revenue, Price and Gross Margin (2019-2021)

12.3.4 Mallinckrodt Main Business Overview

12.3.5 Mallinckrodt Latest Developments

12.4 Amneal Pharma

12.4.1 Amneal Pharma Company Information

12.4.2 Amneal Pharma Opioids Drug Product Offered

12.4.3 Amneal Pharma Opioids Drug Sales, Revenue, Price and Gross Margin (2019-2021)

12.4.4 Amneal Pharma Main Business Overview

12.4.5 Amneal Pharma Latest Developments

12.5 Collegium

12.5.1 Collegium Company Information

12.5.2 Collegium Opioids Drug Product Offered

12.5.3 Collegium Opioids Drug Sales, Revenue, Price and Gross Margin (2019-2021)

12.5.4 Collegium Main Business Overview

12.5.5 Collegium Latest Developments

12.6 J&J

12.6.1 J&J Company Information

12.6.2 J&J Opioids Drug Product Offered

12.6.3 J&J Opioids Drug Sales, Revenue, Price and Gross Margin (2019-2021)

12.6.4 J&J Main Business Overview

12.6.5 J&J Latest Developments

12.7 Endo

12.7.1 Endo Company Information

12.7.2 Endo Opioids Drug Product Offered

12.7.3 Endo Opioids Drug Sales, Revenue, Price and Gross Margin (2019-2021)

12.7.4 Endo Main Business Overview

12.7.5 Endo Latest Developments

12.8 Pfizer

12.8.1 Pfizer Company Information

12.8.2 Pfizer Opioids Drug Product Offered

12.8.3 Pfizer Opioids Drug Sales, Revenue, Price and Gross Margin (2019-2021)

12.8.4 Pfizer Main Business Overview

12.8.5 Pfizer Latest Developments

12.9 INSYS

12.9.1 INSYS Company Information

12.9.2 INSYS Opioids Drug Product Offered

12.9.3 INSYS Opioids Drug Sales, Revenue, Price and Gross Margin (2019-2021)

12.9.4 INSYS Main Business Overview

12.9.5 INSYS Latest Developments

12.10 Mylan

12.10.1 Mylan Company Information

12.10.2 Mylan Opioids Drug Product Offered

12.10.3 Mylan Opioids Drug Sales, Revenue, Price and Gross Margin (2019-2021)

12.10.4 Mylan Main Business Overview

12.10.5 Mylan Latest Developments

12.11 Hikma

12.11.1 Hikma Company Information

12.11.2 Hikma Opioids Drug Product Offered

12.11.3 Hikma Opioids Drug Sales, Revenue, Price and Gross Margin (2019-2021)

12.11.4 Hikma Main Business Overview

12.11.5 Hikma Latest Developments

12.12 Egalet

12.12.1 Egalet Company Information

12.12.2 Egalet Opioids Drug Product Offered

12.12.3 Egalet Opioids Drug Sales, Revenue, Price and Gross Margin (2019-2021)

12.12.4 Egalet Main Business Overview

12.12.5 Egalet Latest Developments

13 Research Findings and Conclusion

List of Tables

Table 1. Opioids Drug Consumption CAGR by Region (2020-2026) & ($ Millions)

Table 2. Major Players of Oxycodone

Table 3. Major Players of Hydromorphone

Table 4. Major Players of Codeine

Table 5. Major Players of Fentanyl

Table 6. Major Players of Others

Table 7. Global Opioids Drug Sales by Type (2016-2021) & (M Units)

Table 8. Global Opioids Drug Sales Market Share by Type (2016-2021)

Table 9. Global Opioids Drug Revenue by Type (2016-2021) & ($ million)

Table 10. Global Opioids Drug Revenue Market Share by Type (2016-2021)

Table 11. Global Opioids Drug Sale Price by Type (2016-2021)

Table 12. Global Opioids Drug Sales by Application (2016-2021) & (M Units)

Table 13. Global Opioids Drug Sales Market Share by Application (2016-2021)

Table 14. Global Opioids Drug Value by Application (2016-2021)

Table 15. Global Opioids Drug Revenue Market Share by Application (2016-2021)

Table 16. Global Opioids Drug Sale Price by Application (2016-2021)

Table 17. Global Opioids Drug Sales by Company (2019-2021) & (M Units)

Table 18. Global Opioids Drug Sales Market Share by Company (2019-2021)

Table 19. Global Opioids Drug Revenue by Company (2019-2021) ($ Millions)

Table 20. Global Opioids Drug Revenue Market Share by Company (2019-2021)

Table 21. Global Opioids Drug Sale Price by Company (2019-2021)

Table 22. Key Manufacturers Opioids Drug Producing Area Distribution and Sales Area

Table 23. Players Opioids Drug Products Offered

Table 24. Opioids Drug Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)

Table 25. New Products and Potential Entrants

Table 26. Mergers & Acquisitions, Expansion

Table 27. Global Opioids Drug Sales by Region (2016-2021) (M Units)

Table 28. Global Opioids Drug Sales Market Share by Region (2016-2021)

Table 29. Global Opioids Drug Revenue by Region (2016-2021) & ($ Millions)

Table 30. Global Opioids Drug Revenue Market Share by Region (2016-2021)

Table 31. Americas Opioids Drug Sales by Country (2016-2021) & (M Units)

Table 32. Americas Opioids Drug Sales Market Share by Country (2016-2021)

Table 33. Americas Opioids Drug Revenue by Country (2016-2021) & ($ Millions)

Table 34. Americas Opioids Drug Revenue Market Share by Country (2016-2021)

Table 35. Americas Opioids Drug Sales by Type (2016-2021) & (M Units)

Table 36. Americas Opioids Drug Sales Market Share by Type (2016-2021)

Table 37. Americas Opioids Drug Sales by Application (2016-2021) & (M Units)

Table 38. Americas Opioids Drug Sales Market Share by Application (2016-2021)

Table 39. APAC Opioids Drug Sales by Region (2016-2021) & (M Units)

Table 40. APAC Opioids Drug Sales Market Share by Region (2016-2021)

Table 41. APAC Opioids Drug Revenue by Region (2016-2021) & ($ Millions)

Table 42. APAC Opioids Drug Revenue Market Share by Region (2016-2021)

Table 43. APAC Opioids Drug Sales by Type (2016-2021) & (M Units)

Table 44. APAC Opioids Drug Sales Market Share by Type (2016-2021)

Table 45. APAC Opioids Drug Sales by Application (2016-2021) & (M Units)

Table 46. APAC Opioids Drug Sales Market Share by Application (2016-2021)

Table 47. Europe Opioids Drug Sales by Country (2016-2021) & (M Units)

Table 48. Europe Opioids Drug Sales Market Share by Country (2016-2021)

Table 49. Europe Opioids Drug Revenue by Country (2016-2021) & ($ Millions)

Table 50. Europe Opioids Drug Revenue Market Share by Country (2016-2021)

Table 51. Europe Opioids Drug Sales by Type (2016-2021) & (M Units)

Table 52. Europe Opioids Drug Sales Market Share by Type (2016-2021)

Table 53. Europe Opioids Drug Sales by Application (2016-2021) & (M Units)

Table 54. Europe Opioids Drug Sales Market Share by Application (2016-2021)

Table 55. Middle East & Africa Opioids Drug Sales by Country (2016-2021) & (M Units)

Table 56. Middle East & Africa Opioids Drug Sales Market Share by Country (2016-2021)

Table 57. Middle East & Africa Opioids Drug Revenue by Country (2016-2021) & ($ Millions)

Table 58. Middle East & Africa Opioids Drug Revenue Market Share by Country (2016-2021)

Table 59. Middle East & Africa Opioids Drug Sales by Type (2016-2021) & (M Units)

Table 60. Middle East & Africa Opioids Drug Sales Market Share by Type (2016-2021)

Table 61. Middle East & Africa Opioids Drug Sales by Application (2016-2021) & (M Units)

Table 62. Middle East & Africa Opioids Drug Sales Market Share by Application (2016-2021)

Table 63. Key and Potential Regions of Opioids Drug

Table 64. Key Application and Potential Industries of Opioids Drug

Table 65. Key Challenges of Opioids Drug

Table 66. Key Trends of Opioids Drug

Table 67. Opioids Drug Distributors List

Table 68. Opioids Drug Customer List

Table 69. Global Opioids Drug Sales Forecast by Region (2021-2026) & (M Units)

Table 70. Global Opioids Drug Consumption Market Forecast by Region

Table 71. Global Opioids Drug Revenue Forecast by Region (2021-2026) & ($ millions)

Table 72. Global Opioids Drug Revenue Market Share Forecast by Region (2021-2026)

Table 73. Americas Opioids Drug Sales Forecast by Country (2021-2026) & (M Units)

Table 74. Americas Opioids Drug Revenue Forecast by Country (2021-2026) & ($ millions)

Table 75. APAC Opioids Drug Sales Forecast by Region (2021-2026) & (M Units)

Table 76. APAC Opioids Drug Revenue Forecast by Region (2021-2026) & ($ millions)

Table 77. Europe Opioids Drug Sales Forecast by Country (2021-2026) & (M Units)

Table 78. Europe Opioids Drug Revenue Forecast by Country (2021-2026) & ($ millions)

Table 79. Middle East & Africa Opioids Drug Sales Forecast by Country (2021-2026) & (M Units)

Table 80. Middle East & Africa Opioids Drug Revenue Forecast by Country (2021-2026) & ($ millions)

Table 81. Global Opioids Drug Sales Forecast by Type (2021-2026) & (M Units)

Table 82. Global Opioids Drug Sales Market Share Forecast by Type (2021-2026)

Table 83. Global Opioids Drug Revenue Forecast by Type (2021-2026) & ($ Millions)

Table 84. Global Opioids Drug Revenue Market Share Forecast by Type (2021-2026)

Table 85. Global Opioids Drug Sales Forecast by Application (2021-2026) & (M Units)

Table 86. Global Opioids Drug Sales Market Share Forecast by Application (2021-2026)

Table 87. Global Opioids Drug Revenue Forecast by Application (2021-2026) & ($ Millions)

Table 88. Global Opioids Drug Revenue Market Share Forecast by Application (2021-2026)

Table 89. Teva Basic Information, Opioids Drug Manufacturing Base, Sales Area and Its Competitors

Table 90. Teva Opioids Drug Product Offered

Table 91. Teva Opioids Drug Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)

Table 92. Teva Main Business

Table 93. Teva Latest Developments

Table 94. Purdue Pharma Basic Information, Opioids Drug Manufacturing Base, Sales Area and Its Competitors

Table 95. Purdue Pharma Opioids Drug Product Offered

Table 96. Purdue Pharma Opioids Drug Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)

Table 97. Purdue Pharma Main Business

Table 98. Purdue Pharma Latest Developments

Table 99. Mallinckrodt Basic Information, Opioids Drug Manufacturing Base, Sales Area and Its Competitors

Table 100. Mallinckrodt Opioids Drug Product Offered

Table 101. Mallinckrodt Opioids Drug Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)

Table 102. Mallinckrodt Main Business

Table 103. Mallinckrodt Latest Developments

Table 104. Amneal Pharma Basic Information, Opioids Drug Manufacturing Base, Sales Area and Its Competitors

Table 105. Amneal Pharma Opioids Drug Product Offered

Table 106. Amneal Pharma Opioids Drug Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)

Table 107. Amneal Pharma Main Business

Table 108. Amneal Pharma Latest Developments

Table 109. Collegium Basic Information, Opioids Drug Manufacturing Base, Sales Area and Its Competitors

Table 110. Collegium Opioids Drug Product Offered

Table 111. Collegium Opioids Drug Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)

Table 112. Collegium Main Business

Table 113. Collegium Latest Developments

Table 114. J&J Basic Information, Opioids Drug Manufacturing Base, Sales Area and Its Competitors

Table 115. J&J Opioids Drug Product Offered

Table 116. J&J Opioids Drug Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)

Table 117. J&J Main Business

Table 118. J&J Latest Developments

Table 119. Endo Basic Information, Opioids Drug Manufacturing Base, Sales Area and Its Competitors

Table 120. Endo Opioids Drug Product Offered

Table 121. Endo Opioids Drug Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)

Table 122. Endo Main Business

Table 123. Endo Latest Developments

Table 124. Pfizer Basic Information, Opioids Drug Manufacturing Base, Sales Area and Its Competitors

Table 125. Pfizer Opioids Drug Product Offered

Table 126. Pfizer Opioids Drug Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)

Table 127. Pfizer Main Business

Table 128. Pfizer Latest Developments

Table 129. INSYS Basic Information, Opioids Drug Manufacturing Base, Sales Area and Its Competitors

Table 130. INSYS Opioids Drug Product Offered

Table 131. INSYS Opioids Drug Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)

Table 132. INSYS Main Business

Table 133. INSYS Latest Developments

Table 134. Mylan Basic Information, Opioids Drug Manufacturing Base, Sales Area and Its Competitors

Table 135. Mylan Opioids Drug Product Offered

Table 136. Mylan Opioids Drug Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)

Table 137. Mylan Main Business

Table 138. Mylan Latest Developments

Table 139. Hikma Basic Information, Opioids Drug Manufacturing Base, Sales Area and Its Competitors

Table 140. Hikma Opioids Drug Product Offered

Table 141. Hikma Opioids Drug Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)

Table 142. Hikma Main Business

Table 143. Hikma Latest Developments

Table 144. Egalet Basic Information, Opioids Drug Manufacturing Base, Sales Area and Its Competitors

Table 145. Egalet Opioids Drug Product Offered

Table 146. Egalet Opioids Drug Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)

Table 147. Egalet Main Business

Table 148. Egalet Latest Developments

List of Figures

Figure 1. Picture of Opioids Drug

Figure 2. Opioids Drug Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Opioids Drug Sales Growth Rate 2016-2026 (M Units)

Figure 7. Global Opioids Drug Revenue Growth Rate 2016-2026 ($ Millions)

Figure 8. Opioids Drug Sales by Region (2021 & 2026) & ($ millions)

Figure 9. Product Picture of Oxycodone

Figure 10. Product Picture of Hydromorphone

Figure 11. Product Picture of Codeine

Figure 12. Product Picture of Fentanyl

Figure 13. Product Picture of Others

Figure 14. Global Opioids Drug Sales Market Share by Type in 2020

Figure 15. Global Opioids Drug Revenue Market Share by Type (2016-2021)

Figure 16. Opioids Drug Consumed in Pain Relief

Figure 17. Global Opioids Drug Market: Pain Relief (2016-2021) & (M Units)

Figure 18. Opioids Drug Consumed in Anesthesia

Figure 19. Global Opioids Drug Market: Anesthesia (2016-2021) & (M Units)

Figure 20. Opioids Drug Consumed in Others

Figure 21. Global Opioids Drug Market: Others (2016-2021) & (M Units)

Figure 22. Global Opioids Drug Sales Market Share by Application (2016-2021)

Figure 23. Global Opioids Drug Revenue Market Share by Application in 2020

Figure 24. Opioids Drug Revenue Market by Company in 2020 ($ Million)

Figure 25. Global Opioids Drug Revenue Market Share by Company in 2020

Figure 26. Global Opioids Drug Sales Market Share by Regions (2016-2021)

Figure 27. Global Opioids Drug Revenue Market Share by Region in 2020

Figure 28. Americas Opioids Drug Sales 2016-2021 (M Units)

Figure 29. Americas Opioids Drug Revenue 2016-2021 ($ Millions)

Figure 30. APAC Opioids Drug Sales 2016-2021 (M Units)

Figure 31. APAC Opioids Drug Revenue 2016-2021 ($ Millions)

Figure 32. Europe Opioids Drug Sales 2016-2021 (M Units)

Figure 33. Europe Opioids Drug Revenue 2016-2021 ($ Millions)

Figure 34. Middle East & Africa Opioids Drug Sales 2016-2021 (M Units)

Figure 35. Middle East & Africa Opioids Drug Revenue 2016-2021 ($ Millions)

Figure 36. Americas Opioids Drug Sales Market Share by Country in 2020

Figure 37. Americas Opioids Drug Revenue Market Share by Country in 2020

Figure 38. Americas Opioids Drug Sales Market Share by Type in 2020

Figure 39. Americas Opioids Drug Sales Market Share by Application in 2020

Figure 40. United States Opioids Drug Revenue Growth 2016-2021 ($ Millions)

Figure 41. Canada Opioids Drug Revenue Growth 2016-2021 ($ Millions)

Figure 42. Mexico Opioids Drug Revenue Growth 2016-2021 ($ Millions)

Figure 43. Brazil Opioids Drug Revenue Growth 2016-2021 ($ Millions)

Figure 44. APAC Opioids Drug Sales Market Share by Region in 2020

Figure 45. APAC Opioids Drug Revenue Market Share by Regions in 2020

Figure 46. APAC Opioids Drug Sales Market Share by Type in 2020

Figure 47. APAC Opioids Drug Sales Market Share by Application in 2020

Figure 48. China Opioids Drug Revenue Growth 2016-2021 ($ Millions)

Figure 49. Japan Opioids Drug Revenue Growth 2016-2021 ($ Millions)

Figure 50. Korea Opioids Drug Revenue Growth 2016-2021 ($ Millions)

Figure 51. Southeast Asia Opioids Drug Revenue Growth 2016-2021 ($ Millions)

Figure 52. India Opioids Drug Revenue Growth 2016-2021 ($ Millions)

Figure 53. Australia Opioids Drug Revenue Growth 2016-2021 ($ Millions)

Figure 54. Europe Opioids Drug Sales Market Share by Country in 2020

Figure 55. Europe Opioids Drug Revenue Market Share by Country in 2020

Figure 56. Europe Opioids Drug Sales Market Share by Type in 2020

Figure 57. Europe Opioids Drug Sales Market Share by Application in 2020

Figure 58. Germany Opioids Drug Revenue Growth 2016-2021 ($ Millions)

Figure 59. France Opioids Drug Revenue Growth 2016-2021 ($ Millions)

Figure 60. UK Opioids Drug Revenue Growth 2016-2021 ($ Millions)

Figure 61. Italy Opioids Drug Revenue Growth 2016-2021 ($ Millions)

Figure 62. Russia Opioids Drug Revenue Growth 2016-2021 ($ Millions)

Figure 63. Middle East & Africa Opioids Drug Sales Market Share by Country in 2020

Figure 64. Middle East & Africa Opioids Drug Revenue Market Share by Country in 2020

Figure 65. Middle East & Africa Opioids Drug Sales Market Share by Type in 2020

Figure 66. Middle East & Africa Opioids Drug Sales Market Share by Application in 2020

Figure 67. Egypt Opioids Drug Revenue Growth 2016-2021 ($ Millions)

Figure 68. South Africa Opioids Drug Revenue Growth 2016-2021 ($ Millions)

Figure 69. Israel Opioids Drug Revenue Growth 2016-2021 ($ Millions)

Figure 70. Turkey Opioids Drug Revenue Growth 2016-2021 ($ Millions)

Figure 71. GCC Country Opioids Drug Revenue Growth 2016-2021 ($ Millions)

Figure 72. Channels of Distribution

Figure 73. Distributors Profiles